<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Angiomax from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Angiomax news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 07:53:12 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Angiomax" rel="self" type="application/rss+xml" />

	
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corpora</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986349&amp;HITNO=0&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986349&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2509109744%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986349&amp;HITNO=0&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986349&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2509109744%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>RBC Dain Rauscher:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986160&amp;HITNO=1&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986160&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508978861%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986160&amp;HITNO=1&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986160&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508978861%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Forbes.com:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corporation</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986002&amp;HITNO=2&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986002&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508904600%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986002&amp;HITNO=2&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986002&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508904600%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corpora</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985958&amp;HITNO=3&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985958&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508884001%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985958&amp;HITNO=3&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985958&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508884001%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corporation</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985935&amp;HITNO=4&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985935&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508878982%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985935&amp;HITNO=4&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985935&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508878982%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corporation</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985846&amp;HITNO=5&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985846&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508840564%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985846&amp;HITNO=5&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985846&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508840564%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corpora</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985837&amp;HITNO=6&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985837&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508837493%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985837&amp;HITNO=6&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985837&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508837493%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corporation</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985782&amp;HITNO=7&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985782&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508805095%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985782&amp;HITNO=7&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985782&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508805095%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp; Co., The Medicines Company and Genzyme Corporation</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985759&amp;HITNO=8&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985759&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508797142%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985759&amp;HITNO=8&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985759&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508797142%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly &amp;</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985730&amp;HITNO=9&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985730&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508782473%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985730&amp;HITNO=9&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985730&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508782473%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire via MSN Money:</description></item>
<item><title>Medicines to cut 10% of staff, close Indiana site</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3911611&amp;HITNO=10&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3911611&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2469736932%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3911611&amp;HITNO=10&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3911611&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2469736932%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Cardiovascular Business:</description></item>
<item><title>Medicines pursues generic Angiomax drugmakers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3873741&amp;HITNO=11&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3873741&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2450144290%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3873741&amp;HITNO=11&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3873741&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2450144290%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Cardiovascular Business:</description></item>
<item><title>Medicines Co. suing Teva, Pliva again over patent</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3864283&amp;HITNO=12&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3864283&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2445928134%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3864283&amp;HITNO=12&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3864283&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2445928134%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Cafepharma:</description></item>
<item><title>Medicines Company files additional patent infringement lawsuits</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3867633&amp;HITNO=13&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3867633&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2447233347%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3867633&amp;HITNO=13&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3867633&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2447233347%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Medicines Co. Suing Teva, Pliva Again Over Patent</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3861777&amp;HITNO=14&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3861777&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444616161%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3861777&amp;HITNO=14&amp;MSIZE=38&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Angiomax&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3861777&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444616161%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drugs.com:</description></item>
</channel></rss>